Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarah J Ballinger

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2021
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast CancerBryan P Schneider, Guanglong Jiang, Tarah J Ballinger, et al.
JAMA Oncology|July 10, 2020
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical TrialMilan Radovich, Guanglong Jiang, Bradley A Hancock, et al.
BMC Medical Informatics and Decision Making|September 28, 2024
Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904)Alissa M Michel, Haeseung Yi, Jacquelyn Amenta, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 17, 2024
NCCN Guidelines® Insights: Survivorship, Version 2.2024Tara Sanft, Andrew T Day, Mindy Goldman, et al.
Journal of the National Cancer Institute|July 2, 2026
Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICEKatherine D Crew, Garnet L Anderson, Kathryn B Arnold, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2025
NCCN Guidelines® Insights: Survivorship, Version 2.2025Tara Sanft, Andrew T Day, Shannon M Ansbaugh, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2021
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast CancerBryan P Schneider, Guanglong Jiang, Tarah J Ballinger, et al.
JAMA Oncology|July 10, 2020
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical TrialMilan Radovich, Guanglong Jiang, Bradley A Hancock, et al.
BMC Medical Informatics and Decision Making|September 28, 2024
Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904)Alissa M Michel, Haeseung Yi, Jacquelyn Amenta, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 17, 2024
NCCN Guidelines® Insights: Survivorship, Version 2.2024Tara Sanft, Andrew T Day, Mindy Goldman, et al.
Journal of the National Cancer Institute|July 2, 2026
Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICEKatherine D Crew, Garnet L Anderson, Kathryn B Arnold, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2025
NCCN Guidelines® Insights: Survivorship, Version 2.2025Tara Sanft, Andrew T Day, Shannon M Ansbaugh, et al.
Pageof 5